Skip to main content

D Kim

First name:
D
Last name:
Kim
Moon, Y. ., Lee, S. ., Kwok, S. ., Lee, S. ., Kim, D. ., Kim, W. ., … Cho, M. . The Fos-Related Antigen 1-JUNB/Activator Protein 1 Transcription Complex, a Downstream Target of Signal Transducer and Activator of Transcription 3, Induces T Helper 17 Differentiation and Promotes Experimental Autoimmune Arthritis. Frontiers in Immunology, 8, 1793. https://doi.org/10.3389/fimmu.2017.01793 (Original work published 2017)
Jeong, S. ., Kim, J. ., Lim, B. ., Yoon, I. ., Song, J. ., Moon, H. ., … Kim, S. . (2018). Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration. Experimental & Molecular Medicine, 50(1), e424. https://doi.org/10.1038/emm.2017.231 (Original work published 2018)
Zhang, W. ., Kim, D. ., Philip, E. ., Miyan, Z. ., Barykina, I. ., Schmidt, B. ., … VIP, study. G. (2013). A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study. Clinical Drug Investigation, 33(4), 263-74. https://doi.org/10.1007/s40261-013-0063-3
Lee, H. ., Hong, B. ., Chung, W. ., Lee, B. ., Lee, S. ., Jeon, D. ., … Choi, D. . (2011). Phase IV, 8-Week, Multicenter, Randomized, Active Treatment-Controlled, Parallel Group, Efficacy, and Tolerability Study of High-Dose Candesartan Cilexetil Combined With Hydrochlorothiazide in Korean Adults With Stage II Hypertension. Clinical Therapeutics, 33(8), 1043-56. https://doi.org/10.1016/j.clinthera.2011.07.002 (Original work published 2011)